Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis
Author:
Affiliation:
1. Division of Gastroenterology and Hepatology; University of Michigan; Ann Arbor MI USA
2. Gastroenterology Section; VA Ann Arbor Healthcare System; Ann Arbor MI USA
3. Department of Biostatistics; University of Michigan; Ann Arbor MI USA
Funder
Valeant Pharmaceuticals International
Michigan Institute for Clinical and Health Research
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15749/fullpdf
Reference47 articles.
1. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013;Beste;Gastroenterology,2015
2. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease;Estes;Hepatology,2018
3. Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents;Moon;Aliment Pharmacol Ther,2017
4. Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States;Parikh;Hepatology,2019
5. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008;Younossi;Clin Gastroenterol Hepatol,2011
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unveiling the protective potential of mirabegron against thioacetamide-induced hepatic encephalopathy in rats: Insights into cAMP/PPAR-γ/p-ERK1/2/p S536 NF-κB p 65 and p-CREB/BDNF/TrkB in parallel with oxidative and apoptotic trajectories;Biochemical Pharmacology;2024-11
2. Medically Tailored Meals for Patients With Cirrhosis and Hepatic Encephalopathy: The BRAINFOOD Proof-of-concept Trial;Journal of Clinical and Experimental Hepatology;2024-11
3. Navigating Cirrhosis: Presentation, Outcomes, and Treatments in Adulthood and Beyond;Current Treatment Options in Gastroenterology;2024-08-23
4. Racial and Ethnic Disparities in Outcomes After the Development of Ascites: A National Cohort Study;Digestive Diseases and Sciences;2024-07-30
5. Rifaximin and alternative agents in the management of irritable bowel syndrome: A comprehensive review;Archiv der Pharmazie;2024-07-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3